Fig. 2
source of infection. (b) and (b’) daily and cumulated total case number simulated for management on the key population to the XFD market. (c) and (c’) daily and cumulated total case number simulated for the close contacts traced with different quarantine protocols. (d) and (d’) daily and cumulated total case number simulated for delayed or earlier expanded Nucleic acid screening on general population. Shading areas indicate 95% confidence intervals
Scenario model simulation to assess the timing of intervention, management of key populations, contact tracing and expanded SARS CoV-2 Nucleic Acid screening. (a) and (a’) daily and cumulated total case number with the 3 day, 7 day, and 14 day delayed identification of XFD market as the